Scope of the Report:

This report focuses on the NK Cell Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for NK Cell Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Chipscreen Biosciences (China)

Affimed NV (Netherlands)

Altor BioScience Corporation (USA)

Innate Pharma SA (France)

Takeda Pharmaceutical (Japan)

Sorrento Therapeutics Inc. (USA)

NantKwest Inc. (USA)

Bristol-Myers Squibb (USA)

NKT Therapeutics (USA)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Mogamulizumab

Lorvotuzumab Mertansine

Others

Market Segment by Applications, can be divided into

Cancer

Cardiovascular Diseases

Others

There are 15 Chapters to deeply display the global NK Cell Therapy market.

Chapter 1, to describe NK Cell Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of NK Cell Therapy, with sales, revenue, and price of NK Cell Therapy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of NK Cell Therapy, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, NK Cell Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe NK Cell Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 NK Cell Therapy Introduction

1.2 Market Analysis by Type

1.2.1 Mogamulizumab

1.2.2 Lorvotuzumab Mertansine

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Cancer

1.3.2 Cardiovascular Diseases

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Chipscreen Biosciences (China)

2.1.1 Business Overview

2.1.2 NK Cell Therapy Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Chipscreen Biosciences (China) NK Cell Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Affimed NV (Netherlands)

2.2.1 Business Overview

2.2.2 NK Cell Therapy Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Affimed NV (Netherlands) NK Cell Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Altor BioScience Corporation (USA)

2.3.1 Business Overview

2.3.2 NK Cell Therapy Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Altor BioScience Corporation (USA) NK Cell Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Innate Pharma SA (France)

2.4.1 Business Overview

2.4.2 NK Cell Therapy Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Innate Pharma SA (France) NK Cell Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Takeda Pharmaceutical (Japan)

2.5.1 Business Overview

2.5.2 NK Cell Therapy Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Takeda Pharmaceutical (Japan) NK Cell Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Sorrento Therapeutics Inc. (USA)

2.6.1 Business Overview

2.6.2 NK Cell Therapy Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sorrento Therapeutics Inc. (USA) NK Cell Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 NantKwest Inc. (USA)

2.7.1 Business Overview

2.7.2 NK Cell Therapy Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 NantKwest Inc. (USA) NK Cell Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Bristol-Myers Squibb (USA)

2.8.1 Business Overview

2.8.2 NK Cell Therapy Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Bristol-Myers Squibb (USA) NK Cell Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 NKT Therapeutics (USA)

2.9.1 Business Overview

2.9.2 NK Cell Therapy Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 NKT Therapeutics (USA) NK Cell Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global NK Cell Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global NK Cell Therapy Sales and Market Share by Manufacturer (2016-2017)

3.2 Global NK Cell Therapy Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 NK Cell Therapy Manufacturer Market Share in 2017

3.3.2 Top 6 NK Cell Therapy Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global NK Cell Therapy Market Analysis by Regions

4.1 Global NK Cell Therapy Sales, Revenue and Market Share by Regions

4.1.1 Global NK Cell Therapy Sales and Market Share by Regions (2013-2018)

4.1.2 Global NK Cell Therapy Revenue and Market Share by Regions (2013-2018)

4.2 North America NK Cell Therapy Sales and Growth Rate (2013-2018)

4.3 Europe NK Cell Therapy Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific NK Cell Therapy Sales and Growth Rate (2013-2018)

4.5 South America NK Cell Therapy Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa NK Cell Therapy Sales and Growth Rate (2013-2018)

5 North America NK Cell Therapy by Countries

5.1 North America NK Cell Therapy Sales, Revenue and Market Share by Countries

5.1.1 North America NK Cell Therapy Sales and Market Share by Countries (2013-2018)

5.1.2 North America NK Cell Therapy Revenue and Market Share by Countries (2013-2018)

5.2 United States NK Cell Therapy Sales and Growth Rate (2013-2018)

5.3 Canada NK Cell Therapy Sales and Growth Rate (2013-2018)

5.4 Mexico NK Cell Therapy Sales and Growth Rate (2013-2018)

6 Europe NK Cell Therapy by Countries

6.1 Europe NK Cell Therapy Sales, Revenue and Market Share by Countries

6.1.1 Europe NK Cell Therapy Sales and Market Share by Countries (2013-2018)

6.1.2 Europe NK Cell Therapy Revenue and Market Share by Countries (2013-2018)

6.2 Germany NK Cell Therapy Sales and Growth Rate (2013-2018)

6.3 UK NK Cell Therapy Sales and Growth Rate (2013-2018)

6.4 France NK Cell Therapy Sales and Growth Rate (2013-2018)

6.5 Russia NK Cell Therapy Sales and Growth Rate (2013-2018)

6.6 Italy NK Cell Therapy Sales and Growth Rate (2013-2018)

7 Asia-Pacific NK Cell Therapy by Countries

7.1 Asia-Pacific NK Cell Therapy Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific NK Cell Therapy Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific NK Cell Therapy Revenue and Market Share by Countries (2013-2018)

7.2 China NK Cell Therapy Sales and Growth Rate (2013-2018)

7.3 Japan NK Cell Therapy Sales and Growth Rate (2013-2018)

7.4 Korea NK Cell Therapy Sales and Growth Rate (2013-2018)

7.5 India NK Cell Therapy Sales and Growth Rate (2013-2018)

7.6 Southeast Asia NK Cell Therapy Sales and Growth Rate (2013-2018)

8 South America NK Cell Therapy by Countries

8.1 South America NK Cell Therapy Sales, Revenue and Market Share by Countries

8.1.1 South America NK Cell Therapy Sales and Market Share by Countries (2013-2018)

8.1.2 South America NK Cell Therapy Revenue and Market Share by Countries (2013-2018)

8.2 Brazil NK Cell Therapy Sales and Growth Rate (2013-2018)

8.3 Argentina NK Cell Therapy Sales and Growth Rate (2013-2018)

8.4 Colombia NK Cell Therapy Sales and Growth Rate (2013-2018)

9 Middle East and Africa NK Cell Therapy by Countries

9.1 Middle East and Africa NK Cell Therapy Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa NK Cell Therapy Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa NK Cell Therapy Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia NK Cell Therapy Sales and Growth Rate (2013-2018)

9.3 UAE NK Cell Therapy Sales and Growth Rate (2013-2018)

9.4 Egypt NK Cell Therapy Sales and Growth Rate (2013-2018)

9.5 Nigeria NK Cell Therapy Sales and Growth Rate (2013-2018)

9.6 South Africa NK Cell Therapy Sales and Growth Rate (2013-2018)

10 Global NK Cell Therapy Market Segment by Type

10.1 Global NK Cell Therapy Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global NK Cell Therapy Sales and Market Share by Type (2013-2018)

10.1.2 Global NK Cell Therapy Revenue and Market Share by Type (2013-2018)

10.2 Mogamulizumab Sales Growth and Price

10.2.1 Global Mogamulizumab Sales Growth (2013-2018)

10.2.2 Global Mogamulizumab Price (2013-2018)

10.3 Lorvotuzumab Mertansine Sales Growth and Price

10.3.1 Global Lorvotuzumab Mertansine Sales Growth (2013-2018)

10.3.2 Global Lorvotuzumab Mertansine Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global NK Cell Therapy Market Segment by Application

11.1 Global NK Cell Therapy Sales Market Share by Application (2013-2018)

11.2 Cancer Sales Growth (2013-2018)

11.3 Cardiovascular Diseases Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 NK Cell Therapy Market Forecast (2018-2023)

12.1 Global NK Cell Therapy Sales, Revenue and Growth Rate (2018-2023)

12.2 NK Cell Therapy Market Forecast by Regions (2018-2023)

12.2.1 North America NK Cell Therapy Market Forecast (2018-2023)

12.2.2 Europe NK Cell Therapy Market Forecast (2018-2023)

12.2.3 Asia-Pacific NK Cell Therapy Market Forecast (2018-2023)

12.2.4 South America NK Cell Therapy Market Forecast (2018-2023)

12.2.5 Middle East and Africa NK Cell Therapy Market Forecast (2018-2023)

12.3 NK Cell Therapy Market Forecast by Type (2018-2023)

12.3.1 Global NK Cell Therapy Sales Forecast by Type (2018-2023)

12.3.2 Global NK Cell Therapy Market Share Forecast by Type (2018-2023)

12.4 NK Cell Therapy Market Forecast by Application (2018-2023)

12.4.1 Global NK Cell Therapy Sales Forecast by Application (2018-2023)

12.4.2 Global NK Cell Therapy Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure NK Cell Therapy Picture

Table Product Specifications of NK Cell Therapy

Figure Global Sales Market Share of NK Cell Therapy by Types in 2017

Table NK Ce